Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tumor Biology

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-015-4264-7PMID 26508026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.

  2017cited by this paper
• Can recurrence and progression be predicted by HYAL-1 expression in primary T1 bladder cancer?

  2015cited by this paper
• Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo.

  2014cited by this paper
• High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

  2014cited by this paper
• Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer.

  2014cited by this paper
• Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis

  2014cited by this paper
• S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells

  2013cited by this paper
• S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma

  2012cited by this paper
• Multifaceted link between cancer and inflammation.

  2012cited by this paper
• The S100A6 calcium‐binding protein regulates endothelial cell‐cycle progression and senescence

  2012cited by this paper
• Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer

  2012cited by this paper
• Bladder cancer and schistosomiasis.

  2012cited by this paper
• Interleukin-36 cytokines enhance the production of host defense peptides psoriasin and LL-37 by human keratinocytes through activation of MAPKs and NF-κB.

  2012cited by this paper
• The Role of S100A4 in the progression of human bladder cancer.

  2012cited by this paper
• Enhanced S100 calcium‐binding protein P expression sensitizes human bladder cancer cells to cisplatin

  2011cited by this paper
• Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation

  2011cited by this paper
• S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

  2010cited by this paper
• S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer

  2010cited by this paper
• Proteomic study of sera from patients with bladder cancer: usefulness of S100A8 and S100A9 proteins.

  2010cited by this paper
• Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase‐2 in patients with bladder cancer

  2010cited by this paper
• Identification of S100A8 and S100A9 as serological markers for colorectal cancer.

  2009cited by this paper
• S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

  2009cited by this paper
• Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer

  2008cited by this paper
• S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation

  2008cited by this paper
• High expression of calcium‐binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma

  2005cited by this paper
• Down-regulation of S100C is associated with bladder cancer progression and poor survival.

  2005cited by this paper

• Orosomucoid 1 interacts with S100A12 and activates ERK signalling to expedite the advancement of bladder cancer

  2024cites this paper
• Uncovering the epidemiology of bladder cancer in the Arab world: A review of risk factors, molecular mechanisms, and clinical features

  2023cites this paper
• Oncoprotein 18 is necessary for malignant cell proliferation in bladder

  2023cites this paper
• Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.

  2023cites this paper
• S100A6 Protein—Expression and Function in Norm and Pathology

  2023cites this paper
• Urinary Biomarkers: Current Status and Future Opportunities

  2021cites this paper
• LncRNA Xist induces arterial smooth muscle cell apoptosis in thoracic aortic aneurysm through miR-29b-3p/Eln pathway.

  2021cites this paper
• Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA

  2020cites this paper
• Decoding and targeting the molecular basis of MACC1-driven metastatic spread: lessons from big data mining and clinical-experimental approaches.

  2020cites this paper
• Optimising the investigation of haematuria and bladder cancer

  2019influential citation
• Long-term Effect of Transurethral Resection of Bladder Tumour Combined with Intravesical Instillation of Pirarubicin on Immune Function in Superficial Bladder Cancer

  2019cites this paper
• The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease.

  2019cites this paper
• The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review.

  2018cites this paper
• Novel urinary biomarkers for the detection of bladder cancer: A systematic review.

  2018cites this paper
• Serum S100 calcium binding protein A4 (S100A4, metatasin) as a diagnostic and prognostic biomarker in epithelial ovarian cancer

  2018cites this paper
• S100A6 – focus on recent developments

  2017cites this paper
• Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.

  2017cites this paper
• Significance of S100A8, S100A9 and calprotectin levels in bladder cancer

  2017cites this paper